DEUTSCHE BANK AG\ - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2022$544,000
+1500.0%
321,602
+2501.3%
0.00%
Q1 2022$34,000
-54.1%
12,363
-10.6%
0.00%
Q4 2021$74,000
-64.9%
13,825
-44.6%
0.00%
Q3 2021$211,000
-85.2%
24,963
-78.6%
0.00%
-100.0%
Q2 2021$1,424,000
+371.5%
116,845
+837.4%
0.00%
Q1 2021$302,000
-30.6%
12,465
-8.1%
0.00%
Q4 2020$435,000
+45.0%
13,560
+36.7%
0.00%
Q3 2020$300,000
-54.6%
9,923
-36.7%
0.00%
-100.0%
Q2 2020$661,000
+94.4%
15,670
+15.0%
0.00%
Q1 2020$340,00013,6250.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders